Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of the International AIDS Society
Published in: Journal of the International AIDS Society 1/2011

Open Access 01-12-2011 | Debate

The HIV/AIDS epidemic in sub-Saharan Africa: thinking ahead on programmatic tasks and related operational research

Authors: Rony Zachariah, Wim Van Damme, Vic Arendt, Jean Claude Schmit, Anthony D Harries

Published in: Journal of the International AIDS Society | Special Issue 1/2011

Login to get access

Abstract

Until now, we have all been desperately trying to run behind the HIV/AIDS epidemic and catch up with it, but despite all our efforts, the epidemic remains well ahead of us. In 2010, the antiretroviral treatment (ART) gap was about 60%, AIDS-related deaths were almost two million a year, and on top of these figures, for every one person started on ART, there were two new HIV infections. What is needed to change this situation is to think ahead of the epidemic in terms of the programmatic tasks we will be faced with and try to act boldly in trying to implement those tasks. From a programmatic perspective, we: a) highlight what needs to fundamentally change in our thinking and overall approach to the epidemic; and b) outline a number of key task areas for implementation and related operational research.
Literature
1.
2.
3.
4.
5.
6.
Zachariah R, Harries AD, Ishikawa N, Rieder HL, Bissell K, Laserson K, Massaquoi M, Van Herp M, Reid T: Operational research in low-income countries: what, why, and how?. Lancet Infect Dis. 2009, 9 (11): 711-717. 10.1016/S1473-3099(09)70229-4.CrossRefPubMed
7.
8.
9.
Mills E, Cooper C, Anema A, Guyatt G: Male circumcision for the prevention of heterosexually acquired HIV infection: a meta-analysis of randomized trials involving 11,050 men. HIV Med. 2008, 9 (6): 332-335. 10.1111/j.1468-1293.2008.00596.x.CrossRefPubMed
10.
Mattson CL, Campbell RT, Bailey RC, Agot K, Ndinya-Achola JO, Moses S: Risk compensation is not associated with male circumcision in Kisumu, Kenya: a multi-faceted assessment of men enrolled in a randomized controlled trial. PLoS One. 2008, 3 (6): e2443.
11.
12.
13.
Weiss HA, Dickson KE, Agot K, Hankins CA: Male circumcision for HIV prevention: current research and programmatic issues. AIDS. 2010, 24 (Suppl 4): S61-69. 10.1097/01.aids.0000390708.66136.f4.PubMedCentralCrossRefPubMed
14.
Fox M, Thomson M: HIV/AIDS and circumcision: lost in translation. J Med Ethics. 2010, 36 (12): 798-801. 10.1136/jme.2010.038695.CrossRefPubMed
15.
16.
17.
18.
Levine R, Oomman N: Global HIV/AIDS funding and health systems: Searching for the win-win. J Acquir Immune Defic Syndr. 2009, 52 (Suppl 1): S3-5.CrossRefPubMed
19.
El-Sadr WM, De Cock KM: Health systems exist for real people. J Acquir Immune Defic Syndr. 2009, 52 (Suppl 1): S1-2.CrossRefPubMed
20.
Sherr K, Pfeiffer J, Mussa A, Vio F, Gimbel S, Micek M, Gloyd S: The role of nonphysician clinicians in the rapid expansion of HIV care in Mozambique. J Acquit Immune Defic Syndr. 2009, 52 (Suppl 1): S20-23.CrossRef
21.
Makombe SD, Jahn A, Tweya H, Chuka S, Yu JK, Hochgesang M, Aberle-Grasse J, Pasulani O, Schouten EJ, Kamoto K, Harries AD: A national survey of the impact of rapid scale-up of antiretroviral therapy on health-care workers in Malawi: effects on human resources and survival. Bull World Health Organ. 2007, 85: 851-857.PubMedCentralPubMed
22.
Mwagomba B, Zachariah R, Massaguoi M, Misindi D, Manzi M, Mandere BC, Bemelmans M, Philips M, Kamoto K, Schouten EJ, Harries AD: Mortality reduction associated with HIV/AIDS care and antiretroviral treatment in rural Malawi: evidence from registers, coffin sales and funerals. PLoS One. 2010, 5 (5): e10452-10.1371/journal.pone.0010452.PubMedCentralCrossRefPubMed
23.
Badri M, Wilson D, Wood R: Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet. 2002, 359: 2059-2064. 10.1016/S0140-6736(02)08904-3.CrossRefPubMed
24.
Lawn SD, Wood R: Antiretroviral therapy for control of the HIV-associated MDR and XDR tuberculosis epidemic in South Africa. Am J Respir Crit Care Med. 2010, 182: 1567-author reply 8-9CrossRefPubMed
25.
Lawn SD, Badri M, Wood R: Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS. 2005, 19: 2109-2116. 10.1097/01.aids.0000194808.20035.c1.CrossRefPubMed
26.
Nakanjako D, Kiragga AN, Castelnuovo B, Kyabayinze DJ, Kamya MR: Low prevalence of Plasmodium falciparum antigenaemia among asymptomatic HAART-treated adults in an urban cohort in Uganda. Malar J. 2011, 10: 66-10.1186/1475-2875-10-66.PubMedCentralCrossRefPubMed
27.
Mermin J, Ekwaru JP, Liechty CA, Were W, Downing R, Ransom R, Weidle P, Lule J, Coutinho A, Solberg P: Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study. Lancet. 2006, 367: 1256-1261. 10.1016/S0140-6736(06)68541-3.CrossRefPubMed
28.
Myer L, Akugizibwe P: Impact of HIV treatment scale-up on women's reproductive health care and reproductive rights in Southern Africa. J Acquir Immune Defic Syndr. 2009, 52 (Suppl 1): S52-53.CrossRefPubMed
29.
Harries AD, Zachariah R, Lawn SD, Rosen S: Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa. Trop Med Int Health. 2010, 52 (Suppl 1): 70-75.CrossRef
30.
Jaffar S, Lazarus JV, Onyebujoh P, Chakaya J, Garrib A, Mwaba P, Mboup S, Bellis K, Egwaga S, Corrah T, Coutinho A: Health services strengthening in Africa-research is a key component. Trop Med Int Health. 2010, 15: 1270-1273. 10.1111/j.1365-3156.2010.02626.x.CrossRefPubMed
31.
Anyangwe SC, Mtonga C: Inequities in the global health workforce: the greatest impediment to health in sub-Saharan Africa. Int J Environ Res Public Health. 2007, 4 (2): 93-100. 10.3390/ijerph2007040002.PubMedCentralCrossRefPubMed
32.
Van Damme W, Kober K, Kegels G: Scaling-up antiretroviral treatment in Southern African countries with human resource shortage: how will health systems adapt?. Soc Sci Med. 2008, 66 (10): 2108-2121. 10.1016/j.socscimed.2008.01.043.CrossRefPubMed
33.
Van Damme W, Kheang ST, Janssens B, Kober K: How labour intensive is a doctor-based delivery model for antiretroviral treatment (ART)? Evidence from an observational study in Siem Reap, Cambodia. Hum Resour Health. 2007, 5: 12-10.1186/1478-4491-5-12.PubMedCentralCrossRefPubMed
34.
Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, Kglatwane J, Kinsman J, Kwasa R, Maridadi J, Moroka TM, Moyo S, Nakiyemba A, Nsimba S, Ogenyi R, Oyabba T, Temu F, Laing R: Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007, 19: 658-665. 10.1080/09540120701244943.CrossRefPubMed
35.
Wools-Kaloustian KK, Sidle JE, Selke HM, Vedanthan R, Kemboi EK, Boit LJ, Jebet VT, Carroll AE, Tierney WM, Kimaiyo S: A model for extending antiretroviral care beyond the rural health centre. J Int AIDS Soc. 2009, 12 (1): 22-10.1186/1758-2652-12-22.PubMedCentralCrossRefPubMed
36.
Jaffar S, Amuron B, Fosters S, Birungi J, Levin J, Namara G, Nabiryo C, Ndembi M, Kyomuhangi R, Opio A, Bunnell R, Tappero JW, Mermin J, Coutinho A, Grosskurth H: Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet. 2009, 374 (9707): 2080-2089. 10.1016/S0140-6736(09)61674-3.PubMedCentralCrossRefPubMed
37.
Decroo T, Telfer B, Biot M, Maikere J, Dezembro S, Cumba LI, Dores CD, Chu K, Ford N: Distribution of antiretroviral treatment through self-forming groups of patients in Tete province, Mozambique. J Acquir Immune Defic Syndr. 2010,
38.
Zachariah R, Reid SD, Chaillet P, Massaguoi M, Schouten EJ, Harries AD: Why do we need a point-of-care CD4 test for low-income countries?. Trop Med Int Health. 2011, 16: 37-41. 10.1111/j.1365-3156.2010.02669.x.CrossRefPubMed
39.
Zachariah R, Ford N, Philips M, Lynch S, Massaguoi M, Janssens V, Harries AD: Task shifting in HIV/AIDS: opportunities, challenges and proposed actions for sub-Saharan Africa. Trans R Soc Trop Med Hyg. 2009, 103 (6): 549-558. 10.1016/j.trstmh.2008.09.019.CrossRefPubMed
40.
Harrington M: Community involvement in HIV and tuberculosis research. J Acquir Immune Defic Syndr. 2009, 52 (Suppl 1): S63-66.CrossRefPubMed
41.
42.
Severe P, Juste MA, Ambroise A, Eliacin L, Marchand C, Apollon S, Edwards A, Bang H, Nicotera J, Godfrey C, Gulick RM, Johnson WD, Pape JW, Fitzgeralc DW: Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N Eng J Med. 2010, 363 (3): 257-265. 10.1056/NEJMoa0910370.CrossRef
43.
Ford N, Kranzer K, Hilderbrand K, Jouquet G, Goemaere E, Vlahakis N, Trivino L, Makakole L, Bygrave H: Early initiation of antiretroviral therapy and associated reduction in mortality, morbidity and defaulting in a nurse-managed, community cohort in Lesotho. AIDS. 2010, 24 (17): 2645-2650. 10.1097/QAD.0b013e32833ec5b2.CrossRefPubMed
44.
Tayler-Smith K, Zachariah R, Massaquoi M, Manzi M, Pasulani O, van den Akker T, Bemelmans M, Bauernfeind A, Mwagomba B, Harries AD: Unacceptable attrition among WHO stages 1 and 2 patients in a hospital-based setting in rural Malawi: can we retain such patients within the general health system?. Trans R Soc Trop Med Hyg. 2010, 104 (5): 313-319. 10.1016/j.trstmh.2010.01.007.CrossRefPubMed
45.
Braitstein P, Einterz RM, Sidle JE, Kimaiyo S, Tierney W: "Talkin' about a revolution": How electronic health records can facilitate the scale-up of HIV care and treatment and catalyze primary care in resource-constrained settings. J Acquir Immune Defic Syndr. 2009, 52 (Suppl 1): S54-57.CrossRefPubMed
46.
Nash D, Elul B, Rabkin M, Tun M, Saito S, Becker M, Nuwagaba-Biribonwoha H: Strategies for more effective monitoring and evaluation systems in HIV programmatic scale-up in resource-limited settings: Implications for health systems strengthening. J Acquir Immune Defic Syndr. 2009, 52 (Supp 1): S58-62.CrossRefPubMed
47.
Douglas GP, Gadabu OJ, Joukes S, Mumba S, McKay MV, Ben-Smith A, Jahn A, Schouten EJ, Landis Lewis Z, van Oosterhout JJ, AIlain TJ, Zachariah R, Berger SD, Harries AD, Chimbwandira F: Using touchscreen electronic medical record systems to support and monitor national scale-up of antiretroviral therapy in Malawi. PLoS Med. 2010, 7 (8):
48.
Siika AM, Rotich JK, Simiyu CJ, Kigotho EM, Smith FE, Sidle JE, Wools-Kaloustian K, Kimaiyo SN, Nyandiko WM, Hannan TJ, Tierney WM: An electronic medical record system for ambulatory care of HIV-infected patients in Kenya. Int J Med Inform. 2005, 74 (5): 345-355. 10.1016/j.ijmedinf.2005.03.002.CrossRefPubMed
49.
Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, Jack W, Habyarimana J, Sadatsafavi M, Najafzadeh M, Marra CA, Estambale B, Ngugi E, Ball TB, Thabane L, Gelmon LJ, Kimani J, Ackers M, Plummer FA: Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenyal): a randomised trial. Lancet. 2010, 376 (9755): 1838-1845. 10.1016/S0140-6736(10)61997-6.CrossRefPubMed
50.
51.
52.
Harries AD, Zachariah R, Corbett EL, Lawn SD, Santos-Filho ET, Chimzizi R, Harrington M, Maher D, Williams BG, De Cock KM: The HIV-associated tuberculosis epidemic--when will we act?. Lancet. 2010, 375 (9729): 1906-1919. 10.1016/S0140-6736(10)60409-6.CrossRefPubMed
53.
Harries AD, Zachariah R, Tayler-Smith K, Schouten EJ, Chimbwandira F, Van Damme W, EI-Sadr WM: Keeping health facilities safe: one way of strengthening the interaction between disease-specific programmes and health systems. Trop Med Int Health. 2010, 15 (12): 1407-1412. 10.1111/j.1365-3156.2010.02662.x.CrossRefPubMed
54.
Van Damme W, Kober K, Kegels G, Laga M: Scaling'3 by 5' to Universal Access requires enhanced prevention. Real Health News. 2006, 5: 29-32.
55.
Montaner JS, Hogg R, Wood E, Kerr T, Tyndall M, Levy AR, Harrigan PR: The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet. 2006, 368 (9534): 531-536. 10.1016/S0140-6736(06)69162-9.CrossRefPubMed
56.
Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, McIntyre J, Lingappa JR, Celum C: Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010, 375 (9731): 2092-2098. 10.1016/S0140-6736(10)60705-2.PubMedCentralCrossRefPubMed
57.
58.
Zachariah R, Harries AD, Philips M, Arnould L, Sabapathy K, O’Brien DP, Ferreyra C, Balkan S: Antiretroviral therapy for HIV prevention: many concerns and challenges, but are there ways forward in sub-Saharan Africa?. Trans R Soc Trop Med Hyg. 2010, 104 (6): 387-391. 10.1016/j.trstmh.2010.01.004.CrossRefPubMed
59.
60.
Grant RM: Antiretroviral agents used by HIV-uninfected persons for prevention: pre- and postexposure prophylaxis. Clin Infect Dis. 2010, 50 (Suppl 3): S96-101.PubMedCentralCrossRefPubMed
61.
Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapia M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernandez T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LG, Mayer KH, Kallas EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P: Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010, 363 (27): 2587-2599. 10.1056/NEJMoa1011205.PubMedCentralCrossRefPubMed
62.
Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany AB, Sibeko S, Mlisana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L, Taylor D: Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010, 329 (5996): 1168-1174. 10.1126/science.1193748.PubMedCentralCrossRefPubMed
63.
Mgone C, Volmink J, Coles D, Makanga M, Jaffar S, Sewankambo N: Linking research and development to strengthen health systems in Africa. Trop Med Int Health. 2010, 15 (12): 1404-1406. 10.1111/j.1365-3156.2010.02661.x.CrossRefPubMed
64.
Zachariah R, Tayler-Smith K, Ngamvithayapong-Yana J, Ota M, Murakami K, Ohkado A, Yamada N, Van Den Boogard W, Draguez B, Ishikawa N, Harries AD: The published research paper: is it an important indicator of successful operational research at programme level?. Trop Med Int Health. 2010, 15 (11): 1274-1277. 10.1111/j.1365-3156.2010.02630.x.CrossRefPubMed
65.
66.
Harries AD, Rusen ID, Reid T, Detjen AK, Berger SD, Bissell K, Hinderaker SG, Edington M, Fussell M, Fujiwara PI, Zachariah R: The Union and Médecins Sans Frontières approach to operational research. Int J Tuberc Lung Dis. 2011, 15 (2): 144-154.PubMed
67.
Thacker SB, Dannenberg AL, Hamilton DH: Epidemic intelligence service of the Centers for Disease Control and Prevention: 50 years of training and service in applied epidemiology. Am J Epidemiol. 2001, 154 (11): 985-992. 10.1093/aje/154.11.985.CrossRefPubMed
Metadata
Title
The HIV/AIDS epidemic in sub-Saharan Africa: thinking ahead on programmatic tasks and related operational research
Authors
Rony Zachariah
Wim Van Damme
Vic Arendt
Jean Claude Schmit
Anthony D Harries
Publication date
01-12-2011
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1758-2652-14-S1-S7

Other articles of this Special Issue 1/2011

Journal of the International AIDS Society 1/2011 Go to the issue

Research

Positive spill-over effects of ART scale up on wider health systems development: evidence from Ethiopia and Malawi

Review

Improving the prevention, diagnosis and treatment of TB among people living with HIV: the role of operational research

Research

Adult mortality in the cities of Bulawayo and Harare, Zimbabwe: 1979-2008

Editorial

Facing up to programmatic challenges created by the HIV/AIDS epidemic in sub-Saharan Africa

Review

Antiretroviral drug supply challenges in the era of scaling up ART in Malawi

Commentary

Treatment as prevention: preparing the way
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits